Earnings Call Insights: Inspire Medical Systems (NYSE:INSP) Q4 2024 CEO Tim Herbert highlighted milestones in 2024, including ...

Inspire Medical Systems appoints Dr. Paul Hoff and Dr. Ruchir Patel as Vice President, Senior Medical Directors to enhance OSA treatment. Inspire Medical Systems, Inc. announced the appointment of ...

NYSE:INSP opened at $144.74 on Monday. Inspire Medical Systems has a one year low of $123.00 and a one year high of $257.40. The business has a fifty day moving average price of $165.31 and a 200 ...

In the latest quarter, 9 analysts provided ratings for Inspire Medical Systems (NYSE:INSP), showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Systems announced that Paul Hoff, an otolaryngologist, and Ruchir Patel, a sleep medicine specialist, will join Inspire ...

Inspire Medical Systems (NYSE:INSP – Get Free Report) had its price objective cut by stock analysts at Stifel Nicolaus from $190.00 to $175.00 in a research note issued on Monday,Benzinga reports.

KeyBanc lowered the firm’s price target on Inspire Medical (INSP) to $216 from $234 and keeps an Overweight rating on the shares. The firm ...

It is hard to get excited after looking at Inspire Medical Systems' (NYSE:INSP) recent performance, when its stock has declined 12% over the past three months. However, the company's fundamentals ...

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Robert W. Baird analyst Michael Polark maintained a Buy rating on Inspire Medical Systems (NYSE:INSP) on Friday, setting a price... Leerink Partners analyst Richard Newitter maintained a Buy ...